Literature DB >> 2856203

Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.

J Gutierrez1, M A López-Nevot, T Cabrera, R Oliva, J Esquivias, F Ruiz-Cabello, F Garrido.   

Abstract

HLA class I and II antigen expression was studied in normal mucosa, adenoma and colon carcinoma. Alkaline phosphatase anti-alkaline phosphatase (APAAP) staining techniques were used in cryostatic sections with anti-HLA-ABC and DR,DP,DQ monoclonal antibodies. All normal mucosa were intensely positive for HLA class I antigen expression, while failing to express class II molecules, except in mucosa adjacent to tumors (15/19 cases). All adenomatous polyps expressed HLA class I antigen, while the intensity of class II expression (DR greater than DQ greater than DP) was paralleled by the degree of dysplasia. In colon carcinoma, the loss of class I expression was seen in 4 out of 32 cases, and class II expression was found to be heterogeneous in 16 of these 32 cases (DR greater than DP greater than DQ). No relationship was noted between class II expression and degree of differentiation. However a correlation was seen between HLA-DR antigen expression and degree of invasiveness, mononuclear infiltrate and prognosis, according to Jass's criteria.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2856203

Source DB:  PubMed          Journal:  Exp Clin Immunogenet        ISSN: 0254-9670


  16 in total

1.  HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Authors:  Giuseppe Sconocchia; Serenella Eppenberger-Castori; Inti Zlobec; Eva Karamitopoulou; Roberto Arriga; Andrea Coppola; Sara Caratelli; Giulio Cesare Spagnoli; Davide Lauro; Alessandro Lugli; Junyi Han; Giandomenica Iezzi; Cristina Ferrone; Amedeo Ferlosio; Luigi Tornillo; Raoul Droeser; Piero Rossi; Antonio Attanasio; Soldano Ferrone; Luigi Terracciano
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

Review 2.  HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.

Authors:  Barbara Seliger; Matthias Kloor; Soldano Ferrone
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

Review 3.  The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.

Authors:  I M Svane; M Boesen; A M Engel
Journal:  Med Oncol       Date:  1999-12       Impact factor: 3.064

4.  HLA antigens are candidate markers for prediction of lymph node metastasis in gastric cancer.

Authors:  K Ogoshi; T Tajima; T Mitomi; K Tsuji
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

5.  HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

Authors:  F Esteban; F Ruiz-Cabello; A Concha; M Pérez-Ayala; J A Sánchez-Rozas; F Garrido
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

6.  Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.

Authors:  F Ruiz-Cabello; M A Lopez Nevot; J Gutierrez; M R Oliva; C Romero; A Ferron; F Esteban; C Huelin; M A Piris; C Rivas
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

7.  Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer.

Authors:  Eva-Maria Surmann; Anita Y Voigt; Sara Michel; Kathrin Bauer; Miriam Reuschenbach; Soldano Ferrone; Magnus von Knebel Doeberitz; Matthias Kloor
Journal:  Cancer Immunol Immunother       Date:  2014-12-02       Impact factor: 6.968

Review 8.  HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy.

Authors:  Per Anderson; Natalia Aptsiauri; Francisco Ruiz-Cabello; Federico Garrido
Journal:  Cell Mol Immunol       Date:  2021-01-20       Impact factor: 22.096

9.  HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.

Authors:  M A López-Nevot; F Esteban; A Ferrón; J Gutiérrez; M R Oliva; C Romero; C Huelin; F Ruiz-Cabello; F Garrido
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

10.  Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.

Authors:  F V Cromme; C J Meijer; P J Snijders; A Uyterlinde; P Kenemans; T Helmerhorst; P L Stern; A J van den Brule; J M Walboomers
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.